Flagship Harbor Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-36
Closed -$2K 2001
2019
Q3
$2K Hold
36
﹤0.01% 1721
2019
Q2
$2K Hold
36
﹤0.01% 1737
2019
Q1
$2K Buy
+36
New +$2.67K ﹤0.01% 1728

Flagship Harbor Advisors's GHDX Position: Q4 2019 in Review

Flagship Harbor Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 36 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Flagship Harbor Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Flagship Harbor Advisors sold 36 Genomic Health, Inc. shares in Q4 2019, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
  • Flagship Harbor Advisors's Genomic Health, Inc. position peaked at $2K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Flagship Harbor Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.